1. Home
  2. USNA vs AXGN Comparison

USNA vs AXGN Comparison

Compare USNA & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USNA
  • AXGN
  • Stock Information
  • Founded
  • USNA 1992
  • AXGN N/A
  • Country
  • USNA United States
  • AXGN United States
  • Employees
  • USNA N/A
  • AXGN N/A
  • Industry
  • USNA Medicinal Chemicals and Botanical Products
  • AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • USNA Health Care
  • AXGN Health Care
  • Exchange
  • USNA Nasdaq
  • AXGN Nasdaq
  • Market Cap
  • USNA 461.9M
  • AXGN 538.3M
  • IPO Year
  • USNA 1996
  • AXGN N/A
  • Fundamental
  • Price
  • USNA $29.82
  • AXGN $11.36
  • Analyst Decision
  • USNA Hold
  • AXGN Strong Buy
  • Analyst Count
  • USNA 1
  • AXGN 6
  • Target Price
  • USNA $36.00
  • AXGN $23.83
  • AVG Volume (30 Days)
  • USNA 174.0K
  • AXGN 722.9K
  • Earning Date
  • USNA 07-22-2025
  • AXGN 05-08-2025
  • Dividend Yield
  • USNA N/A
  • AXGN N/A
  • EPS Growth
  • USNA N/A
  • AXGN N/A
  • EPS
  • USNA 1.82
  • AXGN N/A
  • Revenue
  • USNA $876,242,000.00
  • AXGN $194,520,000.00
  • Revenue This Year
  • USNA $13.04
  • AXGN $18.08
  • Revenue Next Year
  • USNA $7.36
  • AXGN $16.15
  • P/E Ratio
  • USNA $16.32
  • AXGN N/A
  • Revenue Growth
  • USNA N/A
  • AXGN 18.81
  • 52 Week Low
  • USNA $23.10
  • AXGN $6.57
  • 52 Week High
  • USNA $49.16
  • AXGN $21.00
  • Technical
  • Relative Strength Index (RSI)
  • USNA 55.29
  • AXGN 35.32
  • Support Level
  • USNA $29.67
  • AXGN $10.71
  • Resistance Level
  • USNA $30.45
  • AXGN $11.58
  • Average True Range (ATR)
  • USNA 0.67
  • AXGN 0.55
  • MACD
  • USNA -0.12
  • AXGN 0.11
  • Stochastic Oscillator
  • USNA 62.94
  • AXGN 46.43

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Share on Social Networks: